Results 151 to 160 of about 48,298 (265)

Understanding CPVT pathogenic mechanisms based on mutation location within RyR2: towards personalized medicine?

open access: yes
The Journal of Physiology, EarlyView.
Jean‐Pierre Benitah   +2 more
wiley   +1 more source

Cost‐Effectiveness of an Antibacterial Envelope in Patients at High Risk of Cardiac Implantable Electronic Device Infection in the Australian Public Healthcare System

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
Use of an antibacterial envelope in patients at high risk of infection implanted with a cardiac implantable electronic device results in a reduction in infection and an increased quality of life. The incremental cost‐effectiveness ratio is dominant (increases quality of life without increasing cost).
Michelle Hill   +7 more
wiley   +1 more source

Annual Trends and Regional Disparities in Transvenous Lead Extractions in Japan: Insights From the Nationwide Japanese Registry of All Cardiac and Vascular Diseases‐Diagnostic Procedure Combination Data

open access: yesJournal of Arrhythmia, Volume 42, Issue 1, February 2026.
This nationwide analysis of 3573 transvenous lead extraction (TLE) procedures from 108 certified hospitals demonstrated a steady rise in TLEs, driven by increasing non‐infectious indications. Also, TLE use varied across regions, indicating persistent geographic disparities. ABSTRACT Background The increasing use of cardiovascular implantable electronic
Toshihiro Nakamura   +6 more
wiley   +1 more source

Benefits of Implantable Cardioverter-Defibrillator for Secondary Prevention in Patients With Organic Heart Disease. [PDF]

open access: yesAnn Noninvasive Electrocardiol
Akagawa R   +9 more
europepmc   +1 more source

Implantable Cardioverter-Defibrillators [PDF]

open access: yesJAMA, 2006
Janet M. Torpy   +2 more
openaire   +2 more sources

Sodium glucose co‐transporter 2 inhibitors versus dipeptidyl peptidase‐4 inhibitors and the risk of ventricular arrhythmia among patients with type 2 diabetes: A population‐based cohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 935-945, February 2026.
Abstract Aims To determine whether sodium glucose co‐transporter 2 inhibitors (SGLT2i) use, compared with dipeptidyl peptidase‐4 inhibitors (DPP4i) use, is associated with the risk of ventricular arrhythmias (VA) among patients with type 2 diabetes. Materials and Methods We conducted a population‐based cohort study using a prevalent new‐user design and
Wang‐Choi Tang   +5 more
wiley   +1 more source

Predictors of Atrial High‐Rate Episodes and Inappropriate Device Therapy in Implantable Cardioverter Defibrillators

open access: yesPacing and Clinical Electrophysiology, Volume 49, Issue 2, Page 71-81, February 2026.
ABSTRACT Background Implantable cardioverter defibrillator (ICD) therapy can prevent sudden cardiac death, but poses a risk of inappropriate device therapy (IDT), which is linked to worse outcomes and reduced quality of life. On the other hand, ICDs can function as an early warning system for atrial arrhythmias.
Marthe J. Huntelaar   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy